healthcare-thumbnail.png

Consumer Healthcare Market Research Report - Segmented By Type (OTC Pharmaceutical, Dietary Supplements); Application (Retail, Online, Hospitals); and Region - Size, Share, Growth Analysis | Forecast (2023 – 2030)

CONSUMER HEALTHCARE MARKET SIZE (2023 -2030)

The Global Consumer Healthcare Market is valued at USD 391.01 billion in 2024 and is projected to reach a market size of USD 642.22 billion by 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 7.3%.

CONSUMER

Industry Overview: 

Consumer healthcare offers merchandise in wellness, oral health, nutrition, and pores and skin health. Consumer healthcare merchandise in most cases includes over-the-counter (OTC) pills which consist of drugs and vitamin & mineral supplements, which can be bought at once by a patron without a want for a prescription from a healthcare professional. Some toothpaste, mouthwashes, a few styles of eye drops, wart removers, first useful resource lotions, and ointments that incorporate antibiotics and even dandruff shampoos are taken into consideration OTC pills.

Generally, humans who can be affected by not unusual place contamination like cold, cough, headache, and others tend to use commonly-to be had non-pharmaceuticals inside days to be able to cure the contamination. The patron healthcare merchandise essentially consists of the "over-the-counter" (OTC) pills which can be bought without a registered scientific practitioner's prescription. Consumers normally purchase OTC patron healthcare relying on well-known brands. The merchandise includes analgesics, wound care, oral healthcare, medicated pores and skin care, and others.

The not unusual place ailments set off the use of oral healthcare products. The international patron healthcare marketplace is driven by the excessive call for self-medication, growing healthcare expenditures, a growing old populace that is greater liable to disease, deterioration in mental health, and a transition from prescription to over-the-counter medications. The proliferation of wellness & preventive drugs additionally contributes to the marketplace growth.

COVD-19 impact on the Consumer Healthcare Market

COVID-19 first started in Wuhan (China) in December 2019, and since then; it has unfolded at a quick pace throughout the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are a number of the worst affected international locations in phrases of shown instances and mentioned deaths. COVID-19 has been affecting economies and industries in diverse international locations because of lockdowns, tour bans, and enterprise shutdowns. The outbreak has created lots of panic among many of the populace because of which human beings are getting extra careful and postponing pointless visits to doctors and medical shops as a lot as viable for you to exercise social distancing measures to manipulate the contamination transmission. However, developing problems of clients concerning fitness led to accelerated income of immunity boosters worldwide. Hence, it's far envisioned that the OTC client healthcare marketplace may witness an ability boom within the forecast period.

COVID-19 is an incomparable international public fitness emergency that has affected nearly every enterprise, and the long-time period outcomes are projected to affect the enterprise boom for the duration of the forecast period. The ongoing research increases our research framework to ensure the inclusion of underlying COVID-19 problems and cap potential paths forward. The document provides insights on COVID-19 thinking about the adjustments in client conduct and calls for, buying patterns, re-routing of the deliver chain, dynamics of modern-day marketplace forces, and the enormous interventions of governments.

MARKET DRIVERS: 

Awareness approximately lifestyle illnesses is one of the key drivers fueling the client healthcare marketplace boom.

Currently, alternating lifestyles and a loss of balanced weight-reduction plans have led to the occurrence of lifestyle illnesses along with strokes, coronary heart illnesses, obesity, kind diabetes, and atherosclerosis. However, human beings at the moment are turning into aware of those fitness-related problems. This made them regularly flow toward using nutritional supplements, sports activities nutrition, and weight management merchandise. Moreover, the worldwide client healthcare marketplace is developing rapidly, with extra gamers coming into the marketplace with value-brought services in regions such as allergy, digestive fitness, and others. Thus, the growing consciousness approximately lifestyle illnesses will boost the call for OTC prescribed drugs for the duration of the forecast period.

Increasing popularity among customers, growing product attention, and developing earnings amount of OTC are the factors using the OTC customer healthcare marketplace.

Rising possibilities for herbal medicinal merchandise & supplements, developing aged populace coupled with the high quantity of not unusual place illnesses amongst those human beings boosts the marketplace boom.  Growing analgesics adoption for aches and growing product availability at pharmaceutical shops gas the boom of the marketplace. An increasing fee of nearby key gamers with sizeable attention on studies and improvement sports and diverse authorities’ projects for promoting excellent healthcare is anticipated to want the marketplace boom. The boom of the marketplace is specifically accounted for with the aid of using moving calls in the direction of self-medicine and OTC merchandise. Consumer healthcare merchandise does now no longer require a written prescription with the aid of using healthcare specialists and may be bought at once from a drug store. For instance, clients with minor gastrointestinal problems use gastrointestinal medicinal drugs along with laxatives, antidiarrheal, and digestives.

MARKET RESTRAINTS: 

The global customer healthcare market's growth price is anticipated to be impacted via customer abuse and misuse of customer healthcare goods.

A client's misuse or abuse of a product is now no longer uncommon. Many clients make use of gadgets in surprising or accidental ways. According to the Consumer Healthcare Products Association (CHPA), a small however growing huge type of people is abusing lope amide to self-medicate opiate withdrawal or to benefit from a euphoric high. There have additionally been memories of human beings abusing OTC medicines for leisure purposes. A manufacturer might also additionally be held responsible for product damage in lots of situations, even though the user does now no longer use the gadgets as intended.

CONSUMER HEALTHCARE  MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2022 - 2030

Base Year

2022

Forecast Period

2023 - 2030

CAGR

7.3%

Segments Covered

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regional Scope

North America, Europe, APAC, Latin America, Middle East & Africa

Key Companies Profiled

Abbott Laboratories Inc., American Health Corporation, BASF SE, Bayer AG, Bionova Lifesciences, Boehringer Ingelheim GmbH, Eli Lilly and Company, Endo Pharmaceuticals PLC, Gemini Pharmaceuticals, Geneva Biocare, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Ipsen SA, Jasco Group of Companies, Johnson & Johnson Private Ltd, Koninklijke DSM N.V., Lonza Group Ltd., Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., PureTek Corporation, Reckitt Benckiser (RB) Group PLC, Reckitt Benckiser LLC., ROHN HealthCar, Sanofi S.A., Stanex Drugs & Chemicals Pvt. Ltd, Sterling Pharmaceutical Services LLC, Sun Pharmaceutical Industries Limited, Takeda Pharma, and Teva Pharmaceutical Industries Ltd.

Consumer Healthcare Market- By Type

• OTC Pharmaceuticals

• Dietary Supplements

Based on Type, the marketplace is bifurcated into OTC Pharmaceuticals and Dietary Supplements. The nutritional complement is similarly labeled as vitamins, minerals, and others. OTC prescribed drugs have received better marketplace percentage in 2021 and nutritional complement is projected to develop on the quickest CAGR with inside the have a look at period. OTC prescribed drugs are secure and powerful capsules to be used throughout treating not unusual place ailments or slight problems that won't require scientific expert guidance, that's fueling its adoption. The OTC capsules have a better healing index whilst in comparison to the prescribed medicinal drug thus, the opportunity to reason aspect results with the OTC capsules is exceptionally low. Due to this, its adoption is growing among a few customers.

Consumer Healthcare Market- By Application

• Retail

• Online

• Hospitals

On the premise of Application, the Global Consumer Healthcare Market has been segmented into Retail, Online, and Hospitals. Retail software is the most important software location of the patron healthcare marketplace. The Retail phase consists of retail pharmacies and prepared and unorganized retail shops. The retail chain provides the product or the medicine at once to the client imparting a time-saving, handy, and dependable supply of the medicine. Growing fitness focus amongst clients and know-how of the extra offerings supplied with the aid of using prepared gamers shall result in a slow shift from unorganized retail shops in the direction of current retail outlets. The online is predicted to develop on the quickest CAGR, particularly because of rising net penetration and upward thrust in the focus of online blessings throughout the globe.

Consumer Healthcare Market- By Geography

• North America

• Europe

• Asia Pacific

• Rest of the World

On the premise of regional analysis, the Global Consumer Healthcare Market is assessed in North America, Europe, Asia Pacific, and the Rest of the world. North America has emerged because the main location within the Consumer Healthcare marketplace observed with the aid of using Europe, Asia Pacific, and the Rest of the World. The presence of the pinnacle pharmaceutical giant’s within side the location has received an aggressive area for green distribution channels for patron healthcare merchandise throughout the location. Pharmaceutical companies are switching in the direction of imparting patron healthcare merchandise because of prolonged and hard regulatory approval tactics for the prescribed drugs. An increasing call for opportunity drugs having herbal components owing to top-notch blessings is using the call for patron healthcare merchandise throughout Europe. The developing getting old populace within the location is predicted to move a large percentage of the populace in the direction of healthcare dietary supplements and preventive OTC merchandise.

Consumer Healthcare Market Share by Company 

The record profoundly explores the current widespread trends with the aid of using the main companies and innovation profiles inside the Global Consumer Healthcare Market, along with Abbott Laboratories Inc., American Health Corporation, BASF SE, Bayer AG, Bionova Lifesciences, Boehringer Ingelheim GmbH, Eli Lilly and Company, Endo Pharmaceuticals PLC, Gemini Pharmaceuticals, Geneva Biocare, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Ipsen SA, Jasco Group of Companies, Johnson & Johnson Private Ltd, Koninklijke DSM N.V., Lonza Group Ltd., Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., PureTek Corporation, Reckitt Benckiser (RB) Group PLC, Reckitt Benckiser LLC., ROHN HealthCar, Sanofi S.A., Stanex Drugs & Chemicals Pvt. Ltd, Sterling Pharmaceutical Services LLC, Sun Pharmaceutical Industries Limited, Takeda Pharma, and Teva Pharmaceutical Industries Ltd.

NOTABLE HAPPENINGS IN THE GLOBAL CONSUMER HEALTHCARE MARKET IN THE RECENT PAST: 

  • Product Launch: In September 2020 GSK Consumer Healthcare has released a brand-new Advil Dual Action, an extraordinary system that mixes the maximum effective pain-preventing ingredients: ibuprofen and acetaminophen.

  • Product Launch: In October 2020 Abbott launches Duphalac Bears which are fruit-flavored gummy bears that improve children’s digestive fitness and assist them to experience wholesome lives.

  • Product Launch: Reliance General Insurance, one of India’s leading General Insurance companies has launched one of its most flexible and popular products - Reliance Health Gain Policy - on Policybazaar’s online platform, the company announced on 5th September 2022.

  • Acquisition: In September 2022 CVS Health Corp (CVS.N) bought home healthcare services company Signify Health for about $8 billion in cash, a move that will enable one of the largest U.S. healthcare companies to provide further care management to patients in their homes.

Chapter 1. Consumer Healthcare Market– Scope & Methodology
   1.1. Market Segmentation
   1.2. Scope, Assumptions & Limitations
   1.3. Research Methodology
   1.4. Primary Sources
   1.5. Secondary Sources
 
Chapter 2. Consumer Healthcare Market– Executive Summary
   2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
   2.2. Key Trends & Insights
           2.2.1. Demand Side
           2.2.2. Supply Side
   2.4. Attractive Investment Propositions
   2.5. COVID-19 Impact Analysis
 
 
Chapter 3. Consumer Healthcare Market– Competition Scenario
   3.1. Market Share Analysis & Company Benchmarking
   3.2. Competitive Strategy & Development Scenario
   3.3. Competitive Pricing Analysis
   3.4. Supplier-Distributor Analysis
 
 
Chapter 4. Consumer Healthcare Market- Entry Scenario
    4.1. Regulatory Scenario
    4.2. Case Studies – Key Start-ups
    4.3. Customer Analysis
    4.5. PESTLE Analysis
    4.4. Porters Five Force Model
               4.4.1. Bargaining Power of Suppliers
               4.4.2. Bargaining Powers of Customers
               4.4.3. Threat of New Entrants
               4.4.4. Rivalry among Existing Players
                4.4.5. Threat of Substitutes
 
 
Chapter 5. Consumer Healthcare Market- Landscape
   5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
   5.2. Market Drivers
   5.3. Market Restraints/Challenges
   5.4. Market Opportunities
 
 Chapter 6. Consumer Healthcare Market– By Application
  6.1.  Introduction/Key Findings   
6.2    Retail
6.3    Online
6.4     Hospitals
6.5    Y-O-Y Growth trend Analysis By Application 
6.6    Absolute $ Opportunity Analysis By Application, 2023-2030
Chapter 7. Consumer Healthcare Market - By Type
 7.1.  Introduction/Key Findings   
7.2     OTC Pharmaceuticals
7.3    Dietary Supplements
7.4    Y-O-Y Growth trend Analysis By Type
7.5    Absolute $ Opportunity Analysis By Type, 2023-2030
Chapter 8. Consumer Healthcare Market, By Geography – Market Size, Forecast, Trends & Insights
   8.1. North America
                                8.1.1. By Country
                                           8.1.1.1. U.S.A.
                                                8.1.1.2. Canada
                                                8.1.1.3. Mexico

                                    8.1.3 By Application 
8.1.4. By Type

8.1.5. Countries & Segments - Market Attractiveness Analysis
   8.2. Europe
                               8.2.1. By Country
                                                8.2.1. U.K.                         
                                                8.2.2. Germany
                                                8.2.3. France
                                                8.2.4. Italy
                                                8.2.5. Spain
                                                8.2.6. Rest of Europe

                           8.2.2 By Application
8.2.3. By Type

8.2.4. Countries & Segments - Market Attractiveness Analysis
8.3. Asia Pacific
                                8.3.1. By Country
                                                8.3.1. China
                                                8.3.2. Japan
                                                8.3.3. South Korea
                                                8.3.4. India      
                                               8.3.5. Australia & New Zealand
                                                8.3.6. Rest of Asia-Pacific
8.3.2. By Application 
8.3.3. By Type

8.3.4. Countries & Segments - Market Attractiveness Analysis
8.3.5. South America
                                8.4.1. By Country
                                                8.4.1. Brazil
                                                8.4.2. Argentina
                                                8.4.3. Colombia
                                               8.4.4. Chile
                                                8.4.5. Rest of South America                         
                                 8.4.2. By Application
8.4.3. By Type

8.4.4. Countries & Segments - Market Attractiveness Analysis
 8.4.5. Middle East & Africa
                                8.5.1. By Country
                                                8.5.1. United Arab Emirates (UAE)
                                               8.5.2. Saudi Arabia
                                                8.5.3. Qatar
                                                8.5.4. Israel
                                               8.5.5. South Africa
                                                8.5.6. Nigeria
                                                8.5.7. Kenya
                                                8.5.8. Egypt
                                              8.5.9. Rest of MEA
                                              
                                 8.5.3. By Application 
8.5.4. By Type

8.5.5. Countries & Segments - Market Attractiveness Analysis

 Chapter 9. Consumer Healthcare Market– Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
 9.1 Abbott Laboratories Inc.
 9.2  American Health Corporation
9.3 BASF SE
 9.4 Bayer AG
9.5 Bionova Lifesciences
9.6 Boehringer Ingelheim GmbH
9.7 Eli Lilly and Company
9.8 Endo Pharmaceuticals PLC 
9.9 Gemini Pharmaceuticals
9.10 Geneva Biocare
 9.11 GlaxoSmithKline plc
 9.12 Glenmark Pharmaceuticals Ltd.
 9.13 Ipsen SA
 9.14 Jasco Group of Companies
 9.15 Johnson & Johnson Private Ltd
 9.16 Koninklijke DSM N.V.
 9.17 Lonza Group Ltd.
9.18 Novartis AG
9.19 Pfizer Inc.
 9.20 Piramal Enterprises Ltd.
 9.21 PureTek Corporation
9.22 Reckitt Benckiser (RB) Group PL
9.23 Reckitt Benckiser LLC.
9.24 ROHN HealthCar
9.25 Sanofi S.A.
9.26 Stanex Drugs & Chemicals Pvt. Ltd
9.27 Sterling Pharmaceutical Services LLC
9.28 Sun Pharmaceutical Industries Limited
 9.29 Takeda Pharma
9.30 Teva Pharmaceutical Industries Ltd.


 

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.